We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Presepsin Concentrations Predicts Commensurate Decline in Kidney Function

By LabMedica International staff writers
Posted on 06 Jan 2020
Chronic kidney disease (CKD) is a worldwide health problem and its prevalence is rising, particularly in the elderly, mainly reflecting the increased life expectancy of the global population. More...
Decrease in nephron number with aging leads to age-related decline in glomerular filtration rate (GFR).

The risk of developing sepsis increase with age and is higher in patients with CKD. Older patients are particularly susceptible to sepsis because of impaired physical function, comorbidity and hospitalization. The plasma presepsin concentrations of healthy individuals are very slight and have been shown to increase in response to bacterial infections according to disease severity.

Nephrologists at the Nippon Medical School Graduate School of Medicine (Tokyo, Japan) and their colleagues enrolled CKD patients aged ≥65 ye who had visited the nephrology a hospital outpatient department between April 2015 and March 2016. The study also included patients with CKD G5D, that is, stable patients with anuria receiving maintenance hemodialysis (HD), for at least one year at the dialysis unit of the hospital.

Blood samples from each patient were collected by venipuncture at the time of visit and complete blood count and routine biochemical parameters were measured using standard methods. Serum creatinine was measured in serum specimens using automated enzymatic method. Serum cystatin C was measured using a particle-enhanced immunonephelometric assay with the Siemens BN ProSpec nephelometer (Siemens Healthcare Diagnostics, Erlangen Germany). C-reactive protein (CRP) was measured by latex-enhanced immunonephelometric assay with the Siemens BN ProSpec nephelometer. Plasma presepsin concentrations were immediately measured using a Pathfast automated immunoassay analyzer (LSI Medience Corporation, Tokyo, Japan) based on noncompetitive chemiluminescent enzyme immunoassay.

The investigators examined plasma presepsin concentrations of 170 patients (101 men and 69 women and the age of patients ranged from 65 to 97 years, with a median age of 78 (72–85) years. There were 17 patients with CKD G5D (mean HD duration 146 ± 67 months). The mean estimated glomerular filtration rate was 51.8 ± 28.1 mL/min/1.73 m2. Plasma presepsin concentrations in those with CKD G4-G5 (362 pg/mL [273–553]) were significantly higher than in those with CKD G1-G2 (111 pg/mL [91–113]) and CKD G3 (145 pg/mL [124–205]). A high correlation between plasma presepsin concentrations and kidney function was observed.

The authors concluded that increases in plasma presepsin concentrations were exponentially correlated to decline in kidney function in the elderly with CKD and they developed a new prediction equation for plasma presepsin concentrations based on CKD-EPI eGFR Creatinine-Cystatin C equations (eGFRcr-cys). Prediction of plasma presepsin concentrations through commensurate decline in kidney function in the elderly should help in the precise diagnosis of sepsis in clinical practice. The study was published in the January 2020 issue of the journal Clinica Chimica Acta.

Related Links:
Nippon Medical School Graduate School of Medicine
Siemens Healthcare Diagnostics
LSI Medience Corporation



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Lung Cancer Atlas Reveals Cellular Patterns Associated With Patient Prognosis

Lung cancer is a leading cause of cancer-related death worldwide and is characterized by substantial cellular heterogeneity. Even within a single tumor, cancer cells can vary in aggressiveness, while immune,... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: Malaria is caused by Plasmodium parasites, primarily transmitted through the bites of infected female Anopheles mosquitoes (Image Credit: Adobe Stock)

Complete Malaria Genomes Could Improve Species Identification and Surveillance

Malaria remains a major global health challenge, with an estimated 282 million cases and 610,000 deaths worldwide in 2024. Although most research has focused on Plasmodium falciparum, Plasmodium ovale... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.